SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001439222-23-000119
Filing Date
2023-08-03
Accepted
2023-08-03 09:20:06
Documents
72
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q agio-20230630.htm   iXBRL 10-Q 1276899
2 EX-10.2 exhibit102.htm EX-10.2 45071
3 EX-10.3 exhibit103.htm EX-10.3 50034
4 EX-10.4 exhibit104.htm EX-10.4 49839
5 EX-31.1 exhibit31-1x06x30x23.htm EX-31.1 9702
6 EX-31.2 exhibit31-2x06x30x23.htm EX-31.2 9713
7 EX-32.1 exhibit32-1x06x30x23.htm EX-32.1 4695
8 EX-32.2 exhibit32-2x06x30x23.htm EX-32.2 4690
  Complete submission text file 0001439222-23-000119.txt   6075071

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT agio-20230630.xsd EX-101.SCH 40150
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT agio-20230630_cal.xml EX-101.CAL 69512
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT agio-20230630_def.xml EX-101.DEF 156926
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT agio-20230630_lab.xml EX-101.LAB 580339
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT agio-20230630_pre.xml EX-101.PRE 368992
66 EXTRACTED XBRL INSTANCE DOCUMENT agio-20230630_htm.xml XML 734058
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36014 | Film No.: 231138344
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences